SCHEMBL29638087

SCHEMBL29638087

c1ccc(P(c2ccccc2)c2cccc3c2[C@]2(CCc4ccccc42)CC3)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 2/20 0.45
HTR2A P28223 3/20 0.38
KDM1A O60341 1/20 0.36
MAOB P27338 1/20 0.36
SIGMAR1 Q99720 5/20 0.33
CYP3A4 P08684 2/20 0.33
TSHR P16473 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
HDAC9 Q9UKV0 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
HTR2C P28335 2/20 0.32
HTR2B P41595 1/20 0.32
HCAR2 Q8TDS4 1/20 0.32
DRD2 P14416 1/20 0.32
SLC6A2 P23975 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29663718 0.90 DRD1 (0.42) DRD1SIGMAR1CYP3A4TDP1CYP2C9
SCHEMBL29269 0.90 DRD1 (0.42) DRD1SIGMAR1CYP3A4TDP1CYP2C9
SCHEMBL10016849 0.88 DRD1 (0.38) DRD1SIGMAR1CYP3A4TSHRTDP1
SCHEMBL30586769 0.84 DRD1 (0.38) DRD1
SCHEMBL15222147 0.83 DRD1 (0.38) DRD1CYP3A4TDP1ALDH1A1
SCHEMBL15268226 0.82 DRD1 (0.40) DRD1CYP3A4TDP1
SCHEMBL15866604 0.79 DRD1 (0.38) DRD1
SCHEMBL31084186 0.79 DRD1 (0.35) DRD1TDP1ALDH1A1HCAR2
SCHEMBL31084193 0.79 DRD1 (0.35) DRD1TDP1ALDH1A1HCAR2
SCHEMBL17758768 0.79 DRD1 (0.35) DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111484533-B Chiral spiro phosphine-nitrogen-phosphine tridentate ligand and preparation method and application of iridium catalyst thereof 浙江九洲药业股份有限公司 2022-05-06 CN disclosed